137 related articles for article (PubMed ID: 7000060)
1. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
Winter M; Nelson DS; Milton GW
Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
[TBL] [Abstract][Full Text] [Related]
2. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
O'Connor R; MacFarlane JK; Murray D; Thomson DM
Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
Fujisawa T; Waldman SR; Yonemoto RH
Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207
[TBL] [Abstract][Full Text] [Related]
5. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
Plain MJ; Whitehead RH; Jose DG
Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
[TBL] [Abstract][Full Text] [Related]
6. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
7. Effect of serum factors and cell washings on leukocyte adherence inhibition in breast cancer patients.
Fujisawa T; Waldman SR; Yonemoto RH
Gan; 1980 Apr; 71(2):165-72. PubMed ID: 7009300
[TBL] [Abstract][Full Text] [Related]
8. Hemocytometer leukocyte adherence inhibition technique.
Maluish AE; Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
Marti JH; Thomson DM
Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
[TBL] [Abstract][Full Text] [Related]
11. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
14. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
[TBL] [Abstract][Full Text] [Related]
15. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
Lopez M; O'Connor R; MacFarlane JK; Thomson DM
Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
[TBL] [Abstract][Full Text] [Related]
16. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
Müller S; Ernst TM
Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
Thomson DM
Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
[TBL] [Abstract][Full Text] [Related]
18. Superoxide (O2-) assay monocyte adherence test for the detection of cell-mediated immunity in cancer patients.
Yagawa K; Kaku M; Ichinose Y; Hayashi S; Nakanishi M; Nomura Y; Shigematsu N
Oncology; 1987; 44(3):142-4. PubMed ID: 3037461
[TBL] [Abstract][Full Text] [Related]
19. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
Isbister WH
N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
[TBL] [Abstract][Full Text] [Related]
20. Use of leukocyte adherence inhibition test to study the cell mediated antitumour immunity in cancer patients.
Shirodkar SR; Gangal SG
Indian J Med Res; 1979 Jul; 70():88-96. PubMed ID: 387584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
